UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

Value in health, 2010-12, Vol.13 (8), p.922-933

2010

Volltextzugriff (PDF)

Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus

Liver international, 2011-07, Vol.31 (6), p.755-761

2011

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

Value in health, 2015-09, Vol.18 (6), p.800-809

2015

Volltextzugriff (PDF)

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure

Antiviral research, 2014-05, Vol.105, p.112-117

2014

Volltextzugriff (PDF)

A Genetic Analysis of Hepatitis C Virus Transmission between Injection Drug Users

The Journal of infectious diseases, 2002-11, Vol.186 (9), p.1212-1221

2002

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

The New England journal of medicine, 2014-05, Vol.370 (21), p.1993-2001

2014

Volltextzugriff (PDF)

Micro-elimination of HIV and HCV co-infection

The lancet HIV, 2021-02, Vol.8 (2), p.e61-e62

2021

Volltextzugriff (PDF)

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

Journal of hepatology, 2020-06, Vol.72 (6), p.1097-1104

2020

Volltextzugriff (PDF)

Human CD1d-Glycolipid Tetramers Generated by in vitro Oxidative Refolding Chromatography

Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (6), p.3294-3298

2001

Volltextzugriff (PDF)

Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection

Journal of Virology, 2003-02, Vol.77 (3), p.2251-2257

2003

Volltextzugriff (PDF)

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C

Journal of hepatology, 2019-12, Vol.71 (6), p.1099-1105

2019

Volltextzugriff (PDF)

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues

Journal of viral hepatitis, 2018-08, Vol.25 (8), p.886-893

2018

Volltextzugriff (PDF)

Lamivudine combined with hepatitis B immunoglobulin in for prophylaxis of hepatitis B recurrence after liver transplantation: time for a change?

Transplant international, 2009-04, Vol.22 (4), p.385-386

2009

Volltextzugriff (PDF)

Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations

Gut, 2021-03, Vol.70 (3), p.629-630

2021

Volltextzugriff (PDF)

SAT342 - High patient acceptability for a hepatitis C mobile outreach service targeting ‘vulnerable’ homeless communities - an important component for elimination?

Journal of hepatology, 2020-08, Vol.73, p.S826-S826

2020

Volltextzugriff (PDF)

High patient acceptability for a hepatitis C mobile outreach service targeting ‘vulnerable’ homeless communities - an important component for elimination?

Journal of hepatology, 2020-08, Vol.73, p.S826

2020

Volltextzugriff (PDF)

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

The lancet. Gastroenterology & hepatology, 2019-02, Vol.4 (2), p.135-184

2019

Volltextzugriff (PDF)

Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders

Gut, 2016-02, Vol.65 (2), p.340-350

2016

Volltextzugriff (PDF)

PS-181-Unacceptably low SVR rates in African patients with unusual HCV sub-genotypes : Implications for global elimination

Journal of hepatology, 2019-04, Vol.70 (1), p.e111-e112

2019

Volltextzugriff (PDF)

Reply to: “Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action”

Journal of hepatology, 2020-03, Vol.72 (3), p.585-586

2020

Volltextzugriff (PDF)

Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive

Journal of viral hepatitis, 2022-12, Vol.29 (12), p.1079-1088

2022

Volltextzugriff (PDF)

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom

AIDS (London), 2021-08, Vol.35 (10), p.1701-1704

2021

Volltextzugriff (PDF)

Current treatment of hepatitis B

Gut, 2008-01, Vol.57 (1), p.105-124

2008

Volltextzugriff (PDF)

The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: ‘The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa’ by Lemoine et al

Gut, 2016-05, Vol.65 (5), p.882-884

2016

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure

A Genetic Analysis of Hepatitis C Virus Transmission between Injection Drug Users

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

Micro-elimination of HIV and HCV co-infection

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

Human CD1d-Glycolipid Tetramers Generated by in vitro Oxidative Refolding Chromatography

Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues

Lamivudine combined with hepatitis B immunoglobulin in for prophylaxis of hepatitis B recurrence after liver transplantation: time for a change?

Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations

SAT342 - High patient acceptability for a hepatitis C mobile outreach service targeting ‘vulnerable’ homeless communities - an important component for elimination?

High patient acceptability for a hepatitis C mobile outreach service targeting ‘vulnerable’ homeless communities - an important component for elimination?

Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders

PS-181-Unacceptably low SVR rates in African patients with unusual HCV sub-genotypes : Implications for global elimination

Reply to: “Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action”

Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom

Current treatment of hepatitis B

Suchergebnisse filtern